TYK-00540
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for TYK-00540, covering 2025-04-29 to 2025-08-05. Get the full timeline:
Most recent: Clinical Trial Update: Study of TYK-00540 Combined With Enzalutamide in Patients With Metastatic Castration-resistant Prostate Cancer（mCRPC） [Phase 1, Phase 2]